Side-by-side comparison of AI visibility scores, market position, and capabilities
Munich YC cocoa-free ChoViva chocolate (sunflower+oats, 80% less CO2) in 42,000+ EU stores; $74.2M total ($30M Series B Dec 2024 Burda/Zintinus) with Barry Callebaut partnership Nov 2025 competing with Voyage Foods for cocoa supply chain disruption.
Planet A Foods is a Munich, Germany-based food technology company — backed by Y Combinator with $74.2 million in total funding including a $30 million Series B in December 2024 co-led by Burda Principal Investments and Zintinus, and a $15.4 million Series A in February 2024, with investors including World Fund, Bayern Kapital, Cherry Ventures, Tengelmann Ventures, BayWa Venture, and Omnes Capital — providing chocolate manufacturers and food brands with ChoViva: the world's first commercially available cocoa-free chocolate alternative made from locally sourced sunflower seeds and oats through a proprietary fermentation process that delivers authentic chocolate taste while reducing carbon footprint by up to 80% versus conventional cocoa-based chocolate. Available in 42,000+ European retail stores and expanding to UK, France, and the US, Planet A Foods announced a landmark partnership with Barry Callebaut (world's largest chocolate manufacturer) in November 2025 for global commercialization. Founded in 2021, producing 2,000+ tons/year and targeting 15,000+ tons post-Series B.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.